The last few months have been traumatic as the country is grappling with a deadly second wave of the pandemic and medical oxygen in India h...

Many companies were hopeful that Monday would be much better as various authorities were actively trying to smoothen the flow of essential ...

Considering the criticality in respect of Active Pharmaceutical Ingredients (APIs) and Key Starting Material (KSMs), the companies have sta...

Pharmaceutical companies that market medicines made by third parties in the country will now be held responsible for drug product quality w...

Mumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal...

Many manufactures who undertake production for Indian as well as multinational drug majors are rushing to put GST infrastructure in place.

The All India Organisation of Chemists and Druggists, which represents over 8 lakh chemists, has assured the government that supply of drug...

"We wish to become a multinational pharma company by tapping the foreign markets," Chairman and Founder RC Juneja said.

The Delhi-based firm, which manufactures various over-the-counter products including condoms, said the new facility would produce bulk APIs.

Indians are buying sexual enhancement products like never before, making cos launch innovative products in this segment and sell them hard.

A government proposal to slap anti-dumping duties on Chinese and Mexican imports of two key pharma ingredients will push up the prices of c...

Most companies plan to keep up hiring to scale up Indian operations.

Candidates who put special emphasis on verbal section had all the reasons to smile.

Private Equity (PE) investments in the domestic healthcare and pharma industry have touched around $400 million during the first nine month...

At a time when the US generic drugs market is reeling under price competition, a recent move by the US government to accelerate approvals o...

Formulation drug maker Mankind Pharma has ventured into Rs 2,000 crore over-the-counter (OTC) market and will launch seven products in the ...

Delhi-based Mankind Pharma is holding parleys with some of the leading private equity funds for a private placement deal.